Who Owns Seaport Therapeutics Stock?
NASDAQ: SPTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 73.44%
- Institutions (% of float)
- 112.96%
- Held by insiders
- 34.99%
- Institutional holders
- 94
- Institutions 65.0%
- Insiders 35.0%
- Public and other 0.0%
Who owns Seaport Therapeutics stock?
Institutional investors own about 73.4% of Seaport Therapeutics's shares, spread across 94 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 34.99% of SPTX.
The largest institutional holders are Arch Venture Management, Llc (11.76%), General Atlantic, L.P. (11.40%) and Sofinnova Investments, Inc. (6.66%). Together, the top 10 institutions control 53.6% of shares outstanding. In their latest filings, 8 of the top 10 institutions increased their SPTX positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of SPTX
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Arch Venture Management, Llc | 6.29M | 11.76% | +100.0% |
| General Atlantic, L.P. | 6.10M | 11.40% | 0.0% |
| Sofinnova Investments, Inc. | 3.56M | 6.66% | +100.0% |
| Goldman Sachs Group Inc | 2.18M | 4.07% | +100.0% |
| Trv Gp VI, LLC | 2.06M | 3.85% | +100.0% |
| Canada Pension Plan Investment Board | 1.98M | 3.69% | +100.0% |
| FMR, LLC | 1.84M | 3.43% | +55.1% |
| Foresite Capital Management VI LLC | 1.78M | 3.32% | +100.0% |
| JPMORGAN CHASE & CO | 1.60M | 2.98% | -12.1% |
| Price (T.Rowe) Associates Inc | 1.31M | 2.44% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of SPTX
| Fund | Shares | % Held |
|---|---|---|
| JPMorgan Trust II-JPMorgan Small Cap Growth Fund | 840.93K | 1.57% |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | 494.89K | 0.92% |
| Prudential Sector Funds, Inc.-PGIM Jennison Health Sciences Fund | 438.75K | 0.82% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 426.37K | 0.80% |
| iShares Trust-iShares Russell 2000 ETF | 355.16K | 0.66% |
| T. Rowe Price Health Sciences Fund, Inc. | 299.32K | 0.56% |
| JPMorgan Trust I-JPMorgan Small Cap Blend Fund | 271.50K | 0.51% |
| Fidelity Securities Fund-Fidelity Blue Chip Growth Fund | 235.90K | 0.44% |
| Principal Funds, Inc-SmallCap Fund | 181.50K | 0.34% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 165.44K | 0.31% |
Frequently asked questions
Who is the largest shareholder of Seaport Therapeutics?
Arch Venture Management, Llc is the largest institutional shareholder of SPTX, owning 11.76% of shares outstanding (6.29M shares) as of its latest 13F filing.
What percentage of Seaport Therapeutics is owned by institutions?
Institutions own about 73.4% of SPTX shares and 113.0% of the public float.
How much of Seaport Therapeutics do insiders own?
Insiders, such as officers and directors, own about 34.99% of SPTX shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.